文献速递MDS 与骨髓增殖性肿瘤白血病

慢性中性粒细胞白血病的基因组学

Genomics of chronic neutrophilic leukemia.
PubMed 文献 · Blood · 2016-12-27

慢性中性粒细胞白血病(CNL)是一种独特的骨髓增殖性肿瘤,超过80%的病例携带CSF3R突变,该突变激活受体导致中性粒细胞增殖。世界卫生组织指南已将CSF3R突变纳入CNL诊断标准。近期基因组研究显示CNL与其他慢性髓系恶性肿瘤(如不典型慢性髓系白血病)在SETBP1、剪接体蛋白和表观遗传修饰基因突变上具有共性,部分突变也常见于意义未明的克隆性造血,提示疾病演化比既往认识更复杂,年龄相关的白血病前期克隆过程可能先于CNL发生。

要点

  • CNL中CSF3R突变患病率超过80%,WHO指南已将其纳入诊断标准。
  • CNL与不典型慢性髓系白血病共享SETBP1、剪接体蛋白和表观遗传修饰基因突变。
  • 部分突变常见于意义未明的克隆性造血,提示白血病前期克隆可能先于CNL。

核心结论

  • CNL基因组学认识已超越CSF3R单驱动模式,与其他慢性髓系恶性肿瘤共享多种突变,且部分突变常见于意义未明的克隆性造血,提示疾病演化更复杂。
  • 理解CNL基因组事件的完整景观和时序有助于开发改进的治疗策略。

研究设计与样本

  • 本文为综述,总结慢性中性粒细胞白血病(CNL)的基因组学特征。

主要发现

  • CNL中CSF3R突变患病率超过80%,突变激活受体导致中性粒细胞增殖。
  • CNL与不典型慢性髓系白血病共享SETBP1、剪接体蛋白(SRSF2、U2AF1)和表观遗传修饰因子(TET2、ASXL1)突变。
  • 部分相同突变也常见于意义未明的克隆性造血,提示年龄相关的白血病前期克隆过程可能先于CNL发生。

关键数值与推荐

  • 世界卫生组织指南已将CSF3R突变纳入CNL诊断标准。
  • CSF3R突变相对于SETBP1、表观遗传修饰因子或剪接体突变的获得顺序仅在个别病例报告中确定。

局限性

  • CSF3R突变相对于SETBP1、表观遗传修饰因子或剪接体突变的获得顺序仅在个别病例报告中确定,因此需要进一步研究以理解突变时序对CNL克隆演化和进展的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic neutrophilic leukemia (CNL) is a distinct myeloproliferative neoplasm with a high prevalence (>80%) of mutations in the colony-stimulating factor 3 receptor (CSF3R). These mutations activate the receptor, leading to the proliferation of neutrophils that are a hallmark of CNL. Recently, the World Health Organization guidelines have been updated to include CSF3R mutations as part of the diagnostic criteria for CNL. Because of the high prevalence of CSF3R mutations in CNL, it is tempting to think of this disease as being solely driven by this genetic lesion. However, recent additional genomic characterization demonstrates that CNL has much in common with other chronic myeloid malignancies at the genetic level, such as the clinically related diagnosis atypical chronic myeloid leukemia. These commonalities include mutations in SETBP1, spliceosome proteins (SRSF2, U2AF1), and epigenetic modifiers (TET2, ASXL1). Some of these same mutations also have been characterized as frequent events in clonal hematopoiesis of indeterminate potential, suggesting a more complex disease evolution than was previously understood and raising the possibility that an age-related clonal process of preleukemic cells could precede the development of CNL. The order of acquisition of CSF3R mutations relative to mutations in SETBP1, epigenetic modifiers, or the spliceosome has been determined only in isolated case reports; thus, further work is needed to understand the impact of mutation chronology on the clonal evolution and progression of CNL. Understanding the complete landscape and chronology of genomic events in CNL will help in the development of improved therapeutic strategies for this patient population.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Maxson JE, Tyner JW. Genomics of chronic neutrophilic leukemia. Blood. 2016. PMID: 28028025. doi:10.1182/blood-2016-10-695981

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。